Back
BioVie Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
38
BIVI
BioVie
Last Price:
3.50
Seasonality Move:
13.44%
Sell
30
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-0.57%
Sell
38
BioVie (BIVI)
is a Sell
Is BioVie a Buy, Sell or Hold?
- The current BioVie [BIVI] share price is $3.41. The Score for BIVI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BIVI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.70. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.70
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
BIVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 65 | Buy |
| Chaikin Money Flow: | 2223431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2 - 3.28) | Buy |
| Bollinger Bands (100): | (1.88 - 3.9) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 51.73 | Buy |
| Chaikin Money Flow: | -26155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.74) | Buy |
| Bollinger Bands (100): | (0.28 - 1.54) | Sell |
BIVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.12 | Buy |
| 20-day SMA: | 2.88 | Buy |
| 50-day SMA: | 2.29 | Buy |
| 200-day SMA: | 4.75 | Sell |
| 8-day EMA: | 3.14 | Buy |
| 20-day EMA: | 2.81 | Buy |
| 50-day EMA: | 2.62 | Buy |
| 200-day EMA: | 7.79 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.72 | Sell |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 0.64 | Buy |
| 200-day SMA: | 2.41 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.7 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 5.77 | Sell |
BioVie Earnings Growth & BIVI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $7.39 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
BioVie Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||